Peter S Fenwick Selected Research

PF 956980

1/2015

Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter S Fenwick Research Topics

Disease

9	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2011
5	Inflammation (Inflammations) 01/2022 - 06/2003
1	Disease Progression 01/2022
1	Infections 01/2019

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 01/2022 - 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Leukotriene B4IBA 01/2019
1	Poly I-CIBA 01/2019
1	RoflumilastIBA 01/2019
1	Phosphodiesterase 4 InhibitorsIBA 01/2019
1	AntagomirsIBA 01/2019
1	PolyphenolsIBA 01/2017
1	isorhapontigeninIBA 01/2017
1	ResveratrolIBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2017
1	SmokeIBA 01/2017
1	CXC ChemokinesIBA 04/2016
1	LigandsIBA 04/2016
1	ChemokinesIBA 04/2016
1	CC ChemokinesIBA 04/2016
1	Janus Kinase InhibitorsIBA 01/2015
1	PF 956980IBA 01/2015
1	Chemokine ReceptorsIBA 01/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	PercollIBA 01/2014
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2014
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2014
1	AntioxidantsIBA 03/2011
1	AnionsIBA 06/2003
1	Peroxynitrous Acid (Peroxynitrite)IBA 06/2003
1	Superoxides (Superoxide)IBA 06/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2003

Therapy/Procedure

1	Complementary Therapies (Alternative Medicine) 01/2022
1	Therapeutics 01/2019